...Phase Ib/II trial of XVR011 to treat COVID-19. VIB, UCB Ventures, SFPI-FPIM, V-Bio Ventures, SRIW, Noshaq...

...company Imcyse S.A. raised EUR 21.3 million ($25.8 million) from existing investors Biogenosis, Epimede, LSP, Noshaq...

...play Hyloris Pharmaceuticals SA raised EUR15 million ($16.4 million) in a funding round from Scorpiaux, Noshaq...

...Shinhan-Cognitive Start-up Fund, UTC 2019 Bioventurefund, SRIW and Sambrinvest. Also participating were existing investors SFPI-FPIM, Noshaq...

...in preclinical development to treat influenza A and B strains. The round was led by Noshaq...

...SRIW) and Belgium’s Federal Holding and Investment Company (SFPI), as well as prior investors Biogenosis, Noshaq...